
Ceftinez T 250mg/31.25mg Injection
Marketer
Sitnez Biocare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ceftinez T 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial growth, curbing infection spread. Administration requires a healthcare provider's oversight; strict adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects promptly to your physician. Seek immediate medical attention for allergic manifestations such as rash, pruritus, edema, or dyspnea. Disclose all current medications to your doctor before initiating treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive sedation. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and ample hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Ceftinez T 250mg/31.25mg Injection
No information provided. A rephrased version cannot be provided.
Uses of Ceftinez T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ceftinez T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftinez T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftinez T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftinez T 250mg/31.25mg Injection works:
Ceftinez T Injection (250mg/31.25mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thus boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceftinez T 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftinez T 250mg/31.25mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Ceftinez T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftinez T 250mg/31.25mg Injection may induce drowsiness, blurred vision, or dizziness. Driving is prohibited while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ceftinez T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Ceftinez T 250mg/31.25mg Injection to individuals suffering from severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Ceftinez T 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftinez T 250mg/31.25mg Injection :
Omit a Ceftinez T 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Ceftinez T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
